Managing the Risk of Delamination
On the FDA’s list of drug recalls and enforcement reports, the number of recalls due to delamination is on the rise. Pharmaceutical companies and packaging manufacturers are faced with the challenge of solving this problem as recalls on account of delamination can cost companies a lot of money. Dr Bernhard Hladik of Schott Pharmaceutical Systems presents a new solution: pharmaceutical vials that minimise the risk of delamination.
https://international-pharma.com/wp-content/uploads/2014/03/The-new-type…pdf.pdf